Latest filing published 02 Oct 2026 for CMC Markets plc, €163k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -2.4%Entry £7.39 · Close 22 Oct 2026 £7.21
- -0.3%Entry £7.23 · Close 22 Oct 2026 £7.21
- -3.1%Entry £7.01 · Close at T+90 £6.79
- -1.2%Entry £7.30 · Close 22 Oct 2026 £7.21
- +129.6%Entry £3.14 · Close 22 Oct 2026 £7.21
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
David John Fineberg: trading record in brief
On October 2, 2026, David John Fineberg, Deputy Chief Executive Officer of CMC Markets plc, filed a purchase of EUR 163,358, by far the largest in the record: the following ones are EUR 43,077 (November 28, 2017) and EUR 22,700 (June 15, 2018). The record holds 17 purchases, 8 of them with a known amount, EUR 264,573 in total (median EUR 14,120), and 5 sales, 4 of them with an amount, EUR 102,875. Purchases make up 77% of open-market trades.
For the 14 purchases with a stored 90-day result, the median is -7.1%, with 36% positive: past results as stored, not a forecast.
Since February 9, 2017, 176 filings have been published, 146 of them grants, at 14 to 20 a year. The last twelve months hold 20, including 6 purchases and no sale.
10, 8 and 7 trades by Fineberg fall within 30 days of colleagues at CMC Markets plc, in that order. Of which in the same direction: 9, 8 and 7. In the same order, the colleagues are Matthew Lewis, Lord Cruddas and Laurence Booth. The median publication delay is 3 days.
Companies and markets linked to David John Fineberg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 23,300 shares@ £5.97960.0076% mcap75.3% of flowXLONISIN GB00B14SKR37RNS:9804832Canonical exit: 31 Dec 2026 (T+90)
- 38 shares@ £7.640.0000% mcap12.9% of flowXLONISIN GB00B14SKR37RNS:9761487-0
- 190 shares@ £7.040.0001% mcap0.6% of flowXLONFCA-NSM:8235db55-ee5a-4715-a4b2-561289ee6148-0
- 44 shares@ £6.950.0000% mcap0.1% of flowXLONISIN GB00B14SKR37RNS:9709511-0
- 69,982 sharesOutside a trading venueFCA-NSM:28ca68e1-cb7a-455f-9aff-d670ad994fba-0
- 5,438,425,613 sharesi. Outside a trading venue ii. XLONISIN GB00B14SKR37RNS:9687407-1Canonical exit: 21 Oct 2026 (T+90)
- 4,413,620,786 sharesi. Outside a trading venue ii. XLONISIN GB00B14SKR37RNS:9680441-0Canonical exit: 19 Oct 2026 (T+90)
- 2,286,645,616 sharesOutside a trading venueISIN GB00B14SKR37RNS:9678184-2
- 3,809,020,230 sharesi. Outside a trading venue ii. XLONISIN GB00B14SKR37RNS:9668658-1Canonical exit: 11 Oct 2026 (T+90)
- 0i. Outside a trading venue ii. XLONRNS:c9f69402-0bb2-4940-9328-032ed1f86907-1Canonical exit: 11 Oct 2026 (T+90)
- 42 shares@ £7.030.0000% mcap0.1% of flowXLONRNS:0b15d9fc-d191-4f65-9514-e348d47648fb-0
- 64 shares@ £4.6450.1% of flowXLONRNS:83964020-df1f-46e7-b506-63a65a371d40-0
- 80 shares@ £3.710.1% of flowXLONRNS:70fada81-4469-4644-9eb0-040a516cae45-0
- 86 shares@ £3.500.1% of flowXLONRNS:918094b8-3051-4419-85a2-005176724e89-0
- 92 shares@ £3.260.1% of flowXLONRNS:86e9c0a3-af9a-4534-98ba-bbdf8ee6cf5c-0
- 94 shares@ £3.1950.1% of flowXLONRNS:4cf44391-811c-46d0-8d76-4b3afecf0754-0
- 266 shares@ £3.130.4% of flowXLONRNS:e90e863e-849c-423c-938e-250c39e48180-0Canonical exit: 8 Apr 2026 (T+90)
- 100 shares@ £3.0250.1% of flowXLONRNS:acf57a84-cdc9-4e29-bcfa-1de1e9b724c5-0
- 106 shares@ £2.8050.1% of flowXLONRNS:01d05307-ccd3-4af1-80c3-cff7d92feb44-0
- 140 shares@ £2.1450.1% of flowXLONRNS:911c1284-36ca-4365-a1be-94e8208d70be
- 134 shares@ £2.250.1% of flowXLONRNS:5851815
- 69,561 sharesOutside a trading venueRNS:5817103-0
- 132 shares@ £2.250.1% of flowXLONRNS:5811845
- 1 shares@ £2.290.0% of flowXLONRNS:5787074-0
- 512 shares@ £2.28690.5% of flowXLONRNS:5787072
25 of 176 declarations
